# Aether Therapeutics Inc. — Form D

Aether Therapeutics Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-19. The offering totals $6.6M, of which $4.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-01-19
- Form: D
- Accession: 0002004745-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $4.1M
- Remaining: $2.5M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2024-01-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-502978

## Issuer

- Name: Aether Therapeutics Inc.
- CIK: 0002004745
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4200 MARATHON BOULEVARD, AUSTIN, TX, 78756
- Phone: 760-783-3085

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| John D Harris | Director | Austin, TX |
| Eric K Olson | Director | Washington, UT |
| Wolfgang S Sadee | Director | Austin, TX |
| Jon S Saxe | Director | Austin, TX |
| John D Harris | Executive Officer | Austin, TX |
| Jon S Saxe | Executive Officer | Austin, TX |

## More

- [CIK 2004745 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2004745&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002004745-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.